Plantar involvement correlates with obesity, pain and impaired mobility in epidermolysis bullosa simplex: a retrospective cohort study
Background Epidermolysis bullosa simplex (EBS) is the most common type of EB, a group of rare genodermatoses. Affected individuals suffer from skin blistering and report a high disease burden. In some EBS subtypes, plantar keratoderma (PK) has been described. Objectives This study investigated the p...
Saved in:
Published in | Journal of the European Academy of Dermatology and Venereology Vol. 35; no. 10; pp. 2097 - 2104 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.10.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Epidermolysis bullosa simplex (EBS) is the most common type of EB, a group of rare genodermatoses. Affected individuals suffer from skin blistering and report a high disease burden. In some EBS subtypes, plantar keratoderma (PK) has been described.
Objectives
This study investigated the presence and correlation of PK with body mass index, pain and mobility in EBS.
Methods
Individuals (n = 157) with genetically characterized EBS were included in this retrospective cohort study, and clinical data were collected over 16 years (referral patients to the largest German EB centre). Descriptive statistics and mixed linear models were used to assess correlations.
Results
PK was found in 75.8% of patients beginning at a mean age of 4.3 years. Both focal and diffuse PK were observed, and 60% of adults with localized and severe EBS were preobese or obese, with ˜30% of patients reporting severely reduced mobility. The presence of PK, especially diffuse PK, correlated significantly with local infections, obesity, pain and requirement of a wheelchair.
Conclusion
Along with treating skin fragility and blistering, PK should be considered a potential marker of increased morbidity and may represent a target of EBS therapy development. |
---|---|
Bibliography: | The data within this manuscript were in part presented in a poster at the EB2020 World Congress in London, UK, 20‐23rd January 2020. Conflicts of interest None. Declaration The project was funded by a promotional award issued by the German Foundation for Pediatric Dermatology (Deutsche Stiftung Kinderdermatologie e.V.) to ART and by a grant provided by DEBRA international to ART and CH. ART was supported by the Berta‐Ottenstein‐Programme for Clinician Scientists, Faculty of Medicine, University of Freiburg. Open access funding provided by the DEAL project. Funding source ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0926-9959 1468-3083 |
DOI: | 10.1111/jdv.17336 |